- Home
- COLL vs MGPI Comparison
COLL vs MGPI Comparison
Compare COLL & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- MGPI
- Stock Information
- Founded
- COLL 2002
- MGPI 1941
- Country
- COLL United States
- MGPI United States
- Employees
- COLL N/A
- MGPI N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- MGPI Beverages (Production/Distribution)
- Sector
- COLL Health Care
- MGPI Consumer Staples
- Exchange
- COLL Nasdaq
- MGPI Nasdaq
- Market Cap
- COLL 910.2M
- MGPI 803.7M
- IPO Year
- COLL 2015
- MGPI 1988
- Fundamental
- Price
- COLL $28.07
- MGPI $26.74
- Analyst Decision
- COLL Strong Buy
- MGPI Strong Buy
- Analyst Count
- COLL 5
- MGPI 6
- Target Price
- COLL $43.60
- MGPI $64.50
- AVG Volume (30 Days)
- COLL 438.9K
- MGPI 363.0K
- Earning Date
- COLL 05-08-2025
- MGPI 05-01-2025
- Dividend Yield
- COLL N/A
- MGPI 1.79%
- EPS Growth
- COLL 43.56
- MGPI N/A
- EPS
- COLL 1.86
- MGPI 1.56
- Revenue
- COLL $631,449,000.00
- MGPI $703,625,000.00
- Revenue This Year
- COLL $20.00
- MGPI N/A
- Revenue Next Year
- COLL $3.93
- MGPI N/A
- P/E Ratio
- COLL $15.63
- MGPI $17.26
- Revenue Growth
- COLL 11.41
- MGPI N/A
- 52 Week Low
- COLL $27.28
- MGPI $26.41
- 52 Week High
- COLL $42.29
- MGPI $92.52
- Technical
- Relative Strength Index (RSI)
- COLL 37.90
- MGPI 24.22
- Support Level
- COLL $29.01
- MGPI $27.88
- Resistance Level
- COLL $30.53
- MGPI $30.01
- Average True Range (ATR)
- COLL 0.82
- MGPI 1.02
- MACD
- COLL -0.10
- MGPI -0.25
- Stochastic Oscillator
- COLL 5.73
- MGPI 2.78
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives most of its revenue from the Distillery Solutions segment.